| Document |
Document Title |
|
WO/2023/061999A1 |
The present invention discloses a distinct mode of action of a nickel catalyst to forge C-0 bonds to unlock the mild utilization of N2O as O-atom transfer reagent in the synthesis of complex phenols from the corresponding aryl halides.
|
|
WO/2023/054678A1 |
This organic EL element (1) comprises a light-emitting region (5) disposed between a negative electrode (4) and a positive electrode (3), a first positive-electrode-side organic layer (61), and a second positive-electrode-side organic la...
|
|
WO/2023/055999A1 |
Peptoids, compositions thereof, and methods of using the peptoids. The peptoid may be an antimicrobial peptoid. In some embodiments, the peptoid may be used to treat or prevent a fungal infection, a biofilm produced from a fungal infecti...
|
|
WO/2023/053977A1 |
The present invention provides a method for producing a salt (P) of an organic cation and an organic anion, the method comprising: (1) a step for obtaining a product which contains the salt (P) by subjecting a salt (I) of the organic cat...
|
|
WO/2023/052625A1 |
In a first aspect, the present invention relates to a second-order nonlinear optical device, comprising (i) an active layer and (ii) an electric field generator. The active layer comprises (ia) a matrix material, and (ib) second-order no...
|
|
WO/2023/048168A1 |
The present invention provides a resist composition which contains a base material component (A) and a compound (D0) that is represented by general formula (d0). In the formula, Rd0 represents a fused ring group wherein an aromatic ring ...
|
|
WO/2023/049493A1 |
Disclosed herein are compounds according to Formula (A) wherein the compound comprises at least one C6-30aliphatic moiety. Also disclosed are compositions comprising the compounds that may be useful for delivering agents such as therapeu...
|
|
WO/2023/049919A1 |
The present invention provides novel compounds, compositions and methods for treating, ameliorating, and/or preventing an orthopoxvirus infection in a subject in need thereof. In certain embodiments, the orthopoxvirus infection is caused...
|
|
WO/2023/045729A1 |
The present application relates to a nitrogen-containing compound, an electronic component comprising same, and an electronic apparatus. The nitrogen-containing compound of the present application comprises a fluorenyl group, and benzocy...
|
|
WO/2023/045910A1 |
The present application discloses a small-molecule compound having a naphthol ether structure, and a use thereof. Disclosed in the present application are a compound having a structure represented by general formula (I), a pharmaceutical...
|
|
WO/2023/043803A1 |
Disclosed herein are FABP4 and FABP5 inhibitor compounds and their use in pharmaceutical compositions for treating diseases relating to fatty acid metabolism, including cancer. Also disclosed herein are methods for preparing the disclose...
|
|
WO/2023/040105A1 |
Disclosed is a preparation method for a green visible light-catalyzed acetate compound. In this method, an LED lamp is used as a light source to provide energy, economically available primary, secondary, and tertiary alcohols are used as...
|
|
WO/2023/036868A1 |
The present invention relates to compounds of the formula (I) where X is selected from the group consisting of a single bond, O, N-(C1-C4)-alkyl, N-Ar1, CR5R6, S, S(O) and SO2; Z1 and Z2 are independently selected from hydrogen, -Alk-OH,...
|
|
WO/2023/038114A1 |
Provided are organic nanocrystals that are isolated and dispersed and that have high crystallinity. The organic nanocrystals according to one mode of the present disclosure are formed from an organic compound having π-electron conjugati...
|
|
WO/2023/038481A1 |
The present invention relates to a heteroaryl derivative compound having STAT3 inhibitory activity, and a use thereof. The heteroaryl derivative compound according to the present invention exhibits excellent STAT3-selective inhibitory ac...
|
|
WO/2023/036195A1 |
The present invention relates to a deuterium-substituted benzothiophene derivative, and preparation and use thereof. Specifically, a compound of the present invention has a structure shown in formula I, wherein the definitions of each gr...
|
|
WO/2023/036995A1 |
The present invention relates to compounds of the formula (1), or physiologically tolerable salt thereof in which R is a C2-alkynyl, a C2-alkenyl, a C3-allenyl or a C1-C6-alkyl group, Ar is selected from the group consisting of aryl and ...
|
|
WO/2023/038456A1 |
The present invention relates to a novel compound, and a use thereof for treating emotional behavioral disorders. A pharmaceutical composition containing the novel compound according to the present invention for preventing or treating em...
|
|
WO/2023/038156A1 |
The present invention relates to compounds of the formula (I) where X is selected from the group consisting of a single bond, O, N-(C1-C4)-alkyl, N-Ar1, CR5R6, S, S(O) and SO2; Z1 and Z2 are independently selected from hydrogen, -Alk-OH,...
|
|
WO/2023/031246A1 |
The present invention relates to substituted thiophene compounds and methods useful for inhibiting D-dopachrome tautomerase. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present inventi...
|
|
WO/2023/033355A1 |
The present invention provides: a compound represented by formula 1; an organic electric element comprising a first electrode, a second electrode, and an organic material layer between the first electrode and the second electrode; and an...
|
|
WO/2023/031199A1 |
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of the s...
|
|
WO/2023/031200A1 |
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of the s...
|
|
WO/2023/027118A1 |
This resist composition generates an acid when being exposed to light and changes the solubility with respect to a developer through the action of the acid. The resist composition contains a compound including a cation (C0) represented b...
|
|
WO/2023/026884A1 |
To provide a curable composition that generates little outgas from an obtained cured product. The curable composition includes a radical polymerization initiator represented by formula 1 and a radical polymerizable compound. In formula 1...
|
|
WO/2023/028237A1 |
The disclosure provides novel solid state forms of Compound I chosen from Compound I Phosphate Salt Hydrate Form A, Compound I free form Monohydrate, Compound I Phosphate Salt Methanol Solvate, and Compound I Phosphate Salt MEK Solvate, ...
|
|
WO/2023/028117A1 |
A method of treating a Cisd2 insufficiency-associated disorder. The method includes administering to a subject in need a compound of formula (I). Also disclosed is a method of increasing Cisd2 gene expression.
|
|
WO/2023/027479A1 |
The present application provides: a heterocyclic compound which can significantly improve the service life, efficiency, electrochemical stability, and thermal stability of an organic light-emitting device; and an organic light-emitting d...
|
|
WO/2023/027173A1 |
Provided are a compound represented by formula (1) (in formula (1), N*, R1-R9, L1, L2, L3, Ar1, and Ar2 are as defined in formula (1)), an organic electroluminescent element including the compound, and an electronic device including such...
|
|
WO/2023/022233A1 |
The present invention provides: a fused ring compound which has a high glass transition temperature; a charge transport material for photoelectric conversion elements for imaging elements or a charge blocking material for photoelectric c...
|
|
WO/2023/022417A1 |
Provided is a cyano group-substituted heteroaryl amine derivative which effectively absorbs high-energy external light source in the UV region to minimize damage to organic materials inside an organic electroluminescent device, thus cont...
|
|
WO/2023/016249A1 |
The present invention relates to a method for preparing a 3-aryloxy-3-five-membered heteroaryl-propylamine compound. Specifically, provided in the present invention is a method for preparing a compound of formula I. The method comprises ...
|
|
WO/2023/018052A1 |
Provided is a tertiary amine derivative, which effectively absorbs a high-energy external light source in a UV region so as to minimize damage to organic materials in an organic electroluminescent device, and thus contributes to a substa...
|
|
WO/2023/017269A1 |
The invention relates to compounds of formula (I) and to their use in treating or preventing an inflammatory disease or a disease associated with an undesirable immune response: (I) wherein RA and RB are as defined herein.
|
|
WO/2023/016434A1 |
Provided are compounds of formula (I) which can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. Also provided are pharmaceutical compositions compr...
|
|
WO/2023/013273A1 |
This fused ring compound C has a fused ring F that includes a plurality of monocyclic aromatic rings M. The fused ring F has 11 monocyclic aromatic rings M. Of the 11 monocyclic aromatic rings, no more than two are thiophene. The fused r...
|
|
WO/2023/011028A1 |
The present invention relates to an organic compound, an electronic component and an electronic device. The structural formula of the organic compound of the present invention is represented by formula (I), and when used in an organic el...
|
|
WO/2023/013592A1 |
A resist composition is adopted that contains a resin component, which has a constituent unit represented by general formula (a0-1), and a compound, which is represented by general formula (d0-1). In general formula (a0-1), R0 is a hydro...
|
|
WO/2023/004964A1 |
Disclosed in the present invention is a method for synthesizing 3-bromomethyl-7-chlorobenzo[b]thiophene, the method comprising the following steps: adding a substrate of 3-methyl-7-chlorobenzo[b]thiophene into a C6-C8 straight-chain alka...
|
|
WO/2023/003234A1 |
The present invention provides: a novel compound capable of improving the luminous efficiency, stability and lifespan of an element; an organic electric element using same; and an electronic device thereof.
|
|
WO/2023/003014A1 |
The present disclosure provides, for example, a method for producing 2-(4-cyclopropyl-2-fluoroanilino)-3,4-difluoro-5-[[3-fluoro-
2-(methylsulfamoylamino)pyridin-4-yl]methyl]benzamide or a pharmacologically acceptable salt thereof, or a ...
|
|
WO/2023/003313A1 |
The present invention relates to: an organic compound which is used for an organic layer, such as a hole transport layer or an electron blocking layer, in an organic light-emitting device; and an organic light-emitting device comprising ...
|
|
WO/2023/000435A1 |
A method for preparing a sertaconazole nitrate intermediate. Cyclohexane is used as a solvent, and in the presence of benzoyl peroxide, 3-methyl-7-chlorobenzo[b]thiophene reacts with a bromination reagent to generate 3-bromomethyl-7-chlo...
|
|
WO/2023/288013A2 |
The present invention is directed to novel chemical compositions of matter, and in particular novel MDMA class of compounds having substituted methylenedioxyphenethylamine and substituted amphetamine, having a metabolically labile thioet...
|
|
WO/2023/286057A1 |
Novel chemical compounds having herbicidal activity, agricultural compositions, process for their manufacture and their use in crop protection are provided.
|
|
WO/2023/285788A1 |
A process for preparing a compound of formula (I), or a salt thereof, as defined herein. Also, compounds of formula I and intermediate compounds useful in the preparation of a compound of formula (I).
|
|
WO/2023/279426A1 |
A polysubstituted selenium-containing cyclopent(hex)ene framework derivative and a synthesis method therefor. An arylacetylene compound and an unsaturated selenide reagent are used as reaction raw materials, and, under the action of a fr...
|
|
WO/2023/279280A1 |
Disclosed in the present invention are an inhibitor of 1-methyl-7-chloro-4-((methoxyaryl heteroyl)amino)-N-(arylsulfonyl)-indole-2-carboxamide FBPase having a novel structure, a preparation method therefor, and a pharmaceutical compositi...
|
|
WO/2023/282045A1 |
The present disclosure provides a compound represented by general formula (I). (I) (In the formula, Ara is a group obtained by removing n1 hydrogen atoms from a structure represented by general formula (A), and is bonded to R1 at a porti...
|
|
WO/2023/273997A1 |
An organic compound and an application thereof. The organic compound has a structure represented by formula I, has better stability and photoelectric properties, and can enhance and balance carrier transport, thereby improving device per...
|
